Cytokeratin-18 fragment plasma levels above 150 U/L may reflect even mild liver injury and involve metabolic complications of obesity, especially insulin resistance, disturbed lipid postprandial metabolism, low-grade inflammation and inefficient FGF21 signaling. This evidence concerns the gene FGF21 and Insulin resistance.